Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2018 Feb;44(2):167-178.
doi: 10.1007/s00134-017-5004-9. Epub 2017 Dec 4.

Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis

Tomoko Fujii  1   2 , Riki Ganeko  3 , Yuki Kataoka  4 , Toshi A Furukawa  5 , Robin Featherstone  6 , Kent Doi  7 , Jean-Louis Vincent  8 , Daniela Pasero  9 , René Robert  10 , Claudio Ronco  11 , Sean M Bagshaw  12
Affiliations
Meta-Analysis

Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis

Tomoko Fujii et al. Intensive Care Med. 2018 Feb.

Erratum in

Abstract

Purpose: Polymyxin B-immobilized hemoperfusion (PMX-HP) is an adjuvant therapy for sepsis or septic shock that clears circulating endotoxin. Prior trials have shown that PMX-HP improves surrogate endpoints. We aimed to conduct an evidence synthesis to evaluate the efficacy and safety of PMX-HP in critically ill adult patients with sepsis or septic shock.

Methods: We searched for randomized controlled trials (RCTs) in MEDLINE, EMBASE, the Cochrane Library, the Health Technology Assessment Database, CINAHL, "Igaku Chuo Zasshi", the National Institute of Health Clinical Trials Register, the World Health Organization International Clinical Trials Registry Platform, the University Hospital Medical Information Network Clinical Trials Registry, the reference lists of retrieved articles, and publications by manufacturers of PMX-HP. The primary outcomes were 28-day all-cause mortality, the number of patients with at least one serious adverse event, and organ dysfunction scores. The GRADE methodology for the certainty of evidence was used.

Results: Six trials (857 participants; weighted mean age 62.5 years) proved eligible. Patient-oriented primary outcomes were assessed. The pooled risk ratio (RR) for 28-day mortality associated with PMX-HP was 1.03 [95% confidence interval (CI) 0.78-1.36; I 2 = 25%; n = 797]. The pooled RR for adverse events was 2.17 (95% CI 0.68-6.94; I 2 = 0%; n = 717). Organ dysfunction scores over 24-72 h after PMX-HP treatment did not change significantly (standardized mean difference - 0.26; 95% CI - 0.64 to 0.12; I 2 = 78%; n = 797). The certainty of the body of evidence was judged as low for both benefit and harm using the GRADE methodology.

Conclusions: There is currently insufficient evidence to support the routine use of PMX-HP to treat patients with sepsis or septic shock.

Registration: PROSPERO International Prospective Register of Systematic Reviews (CRD42016038356).

Keywords: Meta-analysis; Polymyxin B-immobilized hemoperfusion; Sepsis; Septic shock; Systematic review.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Navigating the Modern Landscape of Sepsis: Advances in Diagnosis and Treatment.
    Jang JH, Choi E, Kim T, Yeo HJ, Jeon D, Kim YS, Cho WH. Jang JH, et al. Int J Mol Sci. 2024 Jul 5;25(13):7396. doi: 10.3390/ijms25137396. Int J Mol Sci. 2024. PMID: 39000503 Free PMC article. Review.
  • Modifications of peripheral perfusion in patients with vasopressor-dependent septic shock treated with polymyxin B-direct hemoperfusion.
    Sekino M, Murakami Y, Sato S, Shintani R, Kaneko S, Iwasaki N, Araki H, Ichinomiya T, Higashijima U, Hara T. Sekino M, et al. Sci Rep. 2023 May 5;13(1):7295. doi: 10.1038/s41598-023-34084-0. Sci Rep. 2023. PMID: 37147345 Free PMC article.
  • Extracorporeal Therapy in Sepsis.
    Govil D, Kumar GP. Govil D, et al. Indian J Crit Care Med. 2020 Apr;24(Suppl 3):S117-S121. doi: 10.5005/jp-journals-10071-23382. Indian J Crit Care Med. 2020. PMID: 32704217 Free PMC article. Review.
  • The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020).
    Egi M, Ogura H, Yatabe T, Atagi K, Inoue S, Iba T, Kakihana Y, Kawasaki T, Kushimoto S, Kuroda Y, Kotani J, Shime N, Taniguchi T, Tsuruta R, Doi K, Doi M, Nakada TA, Nakane M, Fujishima S, Hosokawa N, Masuda Y, Matsushima A, Matsuda N, Yamakawa K, Hara Y, Sakuraya M, Ohshimo S, Aoki Y, Inada M, Umemura Y, Kawai Y, Kondo Y, Saito H, Taito S, Takeda C, Terayama T, Tohira H, Hashimoto H, Hayashida K, Hifumi T, Hirose T, Fukuda T, Fujii T, Miura S, Yasuda H, Abe T, Andoh K, Iida Y, Ishihara T, Ide K, Ito K, Ito Y, Inata Y, Utsunomiya A, Unoki T, Endo K, Ouchi A, Ozaki M, Ono S, Katsura M, Kawaguchi A, Kawamura Y, Kudo D, Kubo K, Kurahashi K, Sakuramoto H, Shimoyama A, Suzuki T, Sekine S, Sekino M, Takahashi N, Takahashi S, Takahashi H, Tagami T, Tajima G, Tatsumi H, Tani M, Tsuchiya A, Tsutsumi Y, Naito T, Nagae M, Nagasawa I, Nakamura K, Nishimura T, Nunomiya S, Norisue Y, Hashimoto S, Hasegawa D, Hatakeyama J, Hara N, Higashibeppu N, Furushima N, Furusono H, Matsuishi Y, Matsuyama T, Minematsu Y, Miyashita R, Miyatake Y, Moriyasu M, Yamada T, Yamada H, Yamamoto R, Yoshida T, Yoshida Y, Yoshimura J, Yotsumoto R, Yonekura H, Wada T, Watanabe E, Aoki M, Asai H, Abe T, Igarashi Y, Iguch… See abstract for full author list ➔ Egi M, et al. J Intensive Care. 2021 Aug 25;9(1):53. doi: 10.1186/s40560-021-00555-7. J Intensive Care. 2021. PMID: 34433491 Free PMC article.
  • Adjunctive immunotherapeutic agents in patients with sepsis and septic shock: a multidisciplinary consensus of 23.
    Girardis M, Coloretti I, Antonelli M, Berlot G, Busani S, Cortegiani A, De Pascale G, De Rosa FG, De Rosa S, Donadello K, Donati A, Forfori F, Giannella M, Grasselli G, Montrucchio G, Oliva A, Pasero D, Piazza O, Romagnoli S, Tascini C, Viaggi B, Tumbarello M, Viale P. Girardis M, et al. J Anesth Analg Crit Care. 2024 Apr 30;4(1):28. doi: 10.1186/s44158-024-00165-3. J Anesth Analg Crit Care. 2024. PMID: 38689337 Free PMC article.
See all "Cited by" articles

References

    1. Nephron. 2000 Oct;86(2):210 - PubMed
    1. Intensive Care Med. 2008 Sep;34(9):1638-45 - PubMed
    1. Crit Care Med. 2010 May;38(5):1360-9 - PubMed
    1. JAMA. 2009 Jun 17;301(23):2445-52 - PubMed
    1. Shock. 2005 May;23(5):400-5 - PubMed

Publication types

LinkOut - more resources